Skip to main navigation Skip to search Skip to main content

Prior treatment status: Impact on the efficacy and safety of teriflunomide in multiple sclerosis

  • Giancarlo Comi
  • , Mark S. Freedman
  • , José E. Meca-Lallana
  • , Patrick Vermersch
  • , Byoung Joon Kim
  • , Alexander Parajeles
  • , Keith R. Edwards
  • , Ralf Gold
  • , Houari Korideck
  • , Jeffrey Chavin
  • , Elizabeth M. Poole
  • , Patricia K. Coyle
  • IRCCS San Raffaele Hospital
  • University of Ottawa
  • Hospital Virgen de la Arrixaca
  • Universidad Católica San Antonio de Murcia
  • University of Lille Nord de France
  • Sungkyunkwan University
  • San Juan de Dios Hospital
  • Multiple Sclerosis Center of Northeastern New York
  • Ruhr University Bochum
  • Sanofi Pasteur Biologics, LLC
  • Dana-Farber Cancer Institute
  • Bluebird Bio
  • Stony Brook University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Prior treatment status: Impact on the efficacy and safety of teriflunomide in multiple sclerosis'. Together they form a unique fingerprint.
Sort by

Neuroscience

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology